NVO logo

Novo Nordisk A/S (NVO) Short Term Debt

Annual Short Term Debt

$961.80 M
+$750.80 M+355.83%

31 December 2023

NVO Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Short Term Debt

$826.80 M
+$44.15 M+5.64%

30 September 2024

NVO Quarterly Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NVO Short Term Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+355.8%-11.7%
3 y3 years-22.0%+292.6%
5 y5 years+1119.1%+298.5%

NVO Short Term Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-53.8%+355.8%-60.3%+368.9%
5 y5 years-53.8%+1119.1%-60.3%+368.9%
alltimeall time-53.8%>+9999.0%-60.3%>+9999.0%

Novo Nordisk A/S Short Term Debt History

DateAnnualQuarterly
Sept 2024
-
$826.80 M(+5.6%)
June 2024
-
$782.65 M(-46.8%)
Mar 2024
-
$1.47 B(+52.9%)
Dec 2023
$961.80 M(+355.8%)
$961.80 M(+2.7%)
Sept 2023
-
$936.59 M(+2.1%)
June 2023
-
$917.75 M(+401.2%)
Mar 2023
-
$183.13 M(-13.2%)
Dec 2022
$211.00 M(-89.9%)
$211.00 M(-12.9%)
Sept 2022
-
$242.27 M(+37.4%)
June 2022
-
$176.34 M(-15.8%)
Mar 2022
-
$209.49 M(-89.9%)
Dec 2021
$2.08 B(+69.0%)
$2.08 B(+889.1%)
Sept 2021
-
$210.62 M(+1.2%)
June 2021
-
$208.20 M(-80.6%)
Mar 2021
-
$1.08 B(-12.8%)
Dec 2020
$1.23 B(+457.9%)
$1.23 B(+432.6%)
Sept 2020
-
$231.47 M(+9.0%)
June 2020
-
$212.40 M(+15.6%)
Mar 2020
-
$183.72 M(-16.9%)
Dec 2019
$220.99 M(+180.1%)
$220.99 M(+6.5%)
Sept 2019
-
$207.50 M(+8.5%)
June 2019
-
$191.19 M(+14.2%)
Mar 2019
-
$167.41 M(+112.2%)
Dec 2018
$78.89 M(-71.1%)
$78.89 M(+50.5%)
Sept 2018
-
$52.43 M(+36.9%)
June 2018
-
$38.31 M(+1.6%)
Mar 2018
-
$37.69 M(-86.2%)
Dec 2017
$272.99 M(+738.3%)
$272.99 M(+563.4%)
Sept 2017
-
$41.15 M(-84.1%)
June 2017
-
$258.90 M(+194.0%)
Mar 2017
-
$88.06 M(+170.4%)
Dec 2016
$32.57 M(-79.3%)
$32.57 M(-52.5%)
Sept 2016
-
$68.63 M(+13.1%)
June 2016
-
$60.71 M(-1.7%)
Mar 2016
-
$61.73 M(-60.7%)
Dec 2015
$157.17 M(+33.7%)
$157.17 M(+65.4%)
Sept 2015
-
$95.03 M(-14.1%)
June 2015
-
$110.64 M(+28.5%)
Mar 2015
-
$86.11 M(-26.7%)
Dec 2014
$117.55 M(+195.4%)
$117.55 M(+142.8%)
Sept 2014
-
$48.41 M(-34.8%)
June 2014
-
$74.28 M(-49.8%)
Mar 2014
-
$148.04 M(+272.0%)
Dec 2013
$39.79 M(-55.1%)
$39.79 M(-67.2%)
Sept 2013
-
$121.22 M(-3.1%)
June 2013
-
$125.11 M(+142.6%)
Mar 2013
-
$51.56 M(-41.8%)
Dec 2012
$88.62 M(+44.9%)
$88.62 M(-13.0%)
Sept 2012
-
$101.81 M(+56.8%)
June 2012
-
$64.94 M(-5.3%)
Mar 2012
-
$68.54 M(+12.1%)
DateAnnualQuarterly
Dec 2011
$61.17 M(-80.1%)
$61.17 M(-80.2%)
Sept 2011
-
$308.81 M(+79.8%)
June 2011
-
$171.74 M(-10.0%)
Mar 2011
-
$190.80 M(-37.8%)
Dec 2010
$306.83 M(+281.6%)
$306.83 M(+67.7%)
Sept 2010
-
$182.98 M(-65.9%)
June 2010
-
$536.44 M(+185.4%)
Mar 2010
-
$187.93 M(+133.7%)
Dec 2009
$80.40 M(-68.0%)
$80.40 M(+78.4%)
Sept 2009
-
$45.06 M(-47.2%)
June 2009
-
$85.38 M(-66.9%)
Mar 2009
-
$257.94 M(+2.8%)
Dec 2008
$250.96 M(+217.6%)
$250.96 M(+65.1%)
Sept 2008
-
$152.04 M(+55.1%)
June 2008
-
$98.06 M(-24.9%)
Mar 2008
-
$130.64 M(+65.4%)
Dec 2007
$79.01 M(+31.8%)
$79.01 M(+172.6%)
Sept 2007
-
$28.98 M(+61.0%)
June 2007
-
$18.00 M(-48.6%)
Mar 2007
-
$35.00 M(-41.6%)
Dec 2006
$59.97 M(-73.8%)
$59.97 M(+17.6%)
Sept 2006
-
$51.00 M(-8.9%)
June 2006
-
$55.95 M(-70.7%)
Mar 2006
-
$190.79 M(-16.7%)
Dec 2005
$229.00 M(+146.5%)
$229.00 M(+66.0%)
Sept 2005
-
$137.92 M(+42.4%)
June 2005
-
$96.86 M(+30.8%)
Mar 2005
-
$74.04 M(-20.3%)
Dec 2004
$92.91 M(-43.7%)
$92.91 M(+27.2%)
Sept 2004
-
$73.02 M(-10.9%)
June 2004
-
$81.91 M(-37.4%)
Mar 2004
-
$130.91 M(-20.7%)
Dec 2003
$165.01 M(+106.4%)
$165.01 M(+106.4%)
Dec 2002
$79.93 M(-18.4%)
$79.93 M(-18.4%)
Dec 2001
$98.01 M(-3.9%)
$98.01 M(-3.9%)
Dec 2000
$102.01 M(-24.3%)
$102.01 M(-24.3%)
Dec 1999
$134.70 M(-6.9%)
$134.70 M(-6.9%)
Dec 1998
$144.65 M(-26.4%)
$144.65 M(-26.4%)
Dec 1997
$196.55 M(-13.6%)
$196.55 M(-13.6%)
Dec 1996
$227.43 M(+74.0%)
$227.43 M(+74.0%)
Dec 1995
$130.69 M(-45.4%)
$130.69 M(-45.4%)
Dec 1994
$239.22 M(+68.7%)
$239.22 M(+68.7%)
Dec 1993
$141.82 M(-11.0%)
$141.82 M(-11.0%)
Dec 1992
$159.33 M(-30.6%)
$159.33 M(-30.6%)
Dec 1991
$229.50 M(-22.8%)
$229.50 M(-22.8%)
Dec 1990
$297.39 M(+8.7%)
$297.39 M(+8.7%)
Dec 1989
$273.58 M(+49.4%)
$273.58 M(+49.4%)
Dec 1988
$183.09 M(+6.9%)
$183.09 M(+6.9%)
Dec 1987
$171.23 M(+1916.5%)
$171.23 M(+1916.5%)
Dec 1986
$8.49 M(+19.7%)
$8.49 M(+19.7%)
Dec 1985
$7.10 M(-91.8%)
$7.10 M(-91.8%)
Dec 1984
$86.36 M
$86.36 M

FAQ

  • What is Novo Nordisk A/S annual short term debt?
  • What is the all time high annual short term debt for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual short term debt year-on-year change?
  • What is Novo Nordisk A/S quarterly short term debt?
  • What is the all time high quarterly short term debt for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly short term debt year-on-year change?

What is Novo Nordisk A/S annual short term debt?

The current annual short term debt of NVO is $961.80 M

What is the all time high annual short term debt for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual short term debt is $2.08 B

What is Novo Nordisk A/S annual short term debt year-on-year change?

Over the past year, NVO annual short term debt has changed by +$750.80 M (+355.83%)

What is Novo Nordisk A/S quarterly short term debt?

The current quarterly short term debt of NVO is $826.80 M

What is the all time high quarterly short term debt for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly short term debt is $2.08 B

What is Novo Nordisk A/S quarterly short term debt year-on-year change?

Over the past year, NVO quarterly short term debt has changed by -$109.80 M (-11.72%)